Format

Send to

Choose Destination
Endoscopy. 2016 Dec;48(12):1059-1068. Epub 2016 Sep 12.

Peroral endoscopic myotomy: a meta-analysis.

Author information

1
Department of Internal Medicine, Wayne State University School of Medicine, Detroit, Michigan, United States.
2
Developmental Endoscopy Lab, Brigham and Women's Hospital, Boston, Massachusetts, United States.
3
Brigham and Women's Hospital, Boston, Massachusetts, United States.
4
Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States.
5
Division of Gastroenterology, Brigham and Women's Hospital, Boston, Massachusetts, United States.

Abstract

Background and study aim: Peroral endoscopic myotomy (POEM) is a relatively novel minimally invasive technique that is used to treat achalasia and other esophageal motility disorders. We systematically reviewed the medical literature in order to evaluate the safety and efficacy of POEM. Methods: We performed a comprehensive review and meta-analysis of studies published up to March 2016 that reported on clinical outcomes of POEM. Five databases were searched: MEDLINE, EMBASE, Ovid, CINAHL, and Cochrane. Results: A total of 36 studies involving 2373 patients were included in the review. Clinical success (Eckardt score ≤ 3) was achieved in 98 % (95 % confidence interval [CI] 97 % - 100 %) of patients after the procedure. The mean Eckardt score decreased from 6.9 ± 0.15 preoperatively to 0.77 ± 0.10, 1.0 ± 0.10, and 1.0 ± 0.08 within 1, 6, and 12 months of treatment. In addition, there were significant decreases in the average lower esophageal sphincter pressure, integrated relaxation pressure, and the average heights of the barium column following a timed barium esophagogram after the procedure. After a mean follow-up of 8 months post-procedure, the rates of symptomatic gastroesophageal reflux, esophagitis on esophagogastroduodenoscopy, and abnormal acid exposure were 8.5 % (95 %CI 4.9 % - 13 %), 13 % (95 %CI 5.0 % - 23 %), and 47 % (95 %CI 21 % - 74 %), respectively. Conclusions: POEM appears to be safe and effective based on the large body of current evidence, and warrants consideration as first-line therapy when an expert operator is available.

PMID:
27617421
DOI:
10.1055/s-0042-114426
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Georg Thieme Verlag Stuttgart, New York
Loading ...
Support Center